If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
318.60    -7.80 (-2.39%)
Bid:
317.20
Ask:
318.60
Spread: 1.40 (0.441%)
Market Cap: £697.95m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Appointment of CFO

7 Feb 2013 07:00

RNS Number : 3108X
Burford Capital
07 February 2013
 



 

 

7 February 2013

BURFORD CAPITAL APPOINTS CHIEF FINANCIAL OFFICER

Burford also expands US team with new underwriting and finance hires

Burford Capital ("Burford"), the world's largest provider of investment capital and risk solutions for litigation, today announces the appointment of Miriam Connole as its Chief Financial Officer. Ms. Connole, who will be responsible for the global financial affairs of the company, will be based in Burford's London office. This is a new position at Burford; Burford previously relied on outsourced financial management and its other executive resources and the cost of this position is expected to be largely recouped from cost reductions elsewhere.

Ms. Connole most recently served as Group Commercial Finance Director of Friends Life Group, a leading UK insurer. Previously, she was the Chief Financial Officer of RSA's Central & Eastern European region. She has worked in the insurance industry for the past eleven years, during which time she also gained extensive international finance and insurance experience at both AIG and ACE.

Before entering the insurance industry, Miriam qualified as a Chartered Accountant with Arthur Andersen in Ireland and spent several years there in the audit practice. She graduated with a Masters of Accounting from University College Dublin and a Bachelor of Commerce Degree from University College Galway.

Commenting on Ms. Connole's hire, Christopher Bogart, Burford Capital's CEO, said: "With Burford's business expanding significantly over the past year, it is time to enlist someone of Miriam's expertise and experience as CFO. We are delighted to have found someone with her international perspective, tax background, and deep involvement in the financial services industry."

In addition to Ms. Connole's appointment, Burford announces it has recently added two new members to its team in New York: Andrew Cohen, formerly of Debevoise & Plimpton, and Christina Yue, formerly of Ernst & Young.

Mr. Cohen, who is joining as a Vice President in Burford's underwriting and investment arm, was a senior litigation associate at Debevoise & Plimpton, a major US law firm, where he specialized in litigation and regulatory matters involving financial institutions and complex financial products, as well as IP matters relating to trademark disputes. He regularly represented financial institutions and public companies before state Attorneys General, the SEC, and the DOJ in investigations into complex securities including auction rate securities and MBS, accounting issues and Foreign Corrupt Practices Act violations. Mr. Cohen graduated from Columbia Law School, where he was a Stone Scholar and an editor of the Columbia Law Review.

Ms. Yue, who is joining as Vice President, Finance, was most recently a manager at Ernst & Young auditing large hedge funds, fund of funds, and mutual funds that collectively have more than $20 billion in assets under management. She graduated magna cum laude from SUNY Binghamton with a BSC in Accounting.

Commenting on the two appointments, Mr. Bogart said: "Burford is always seeking exceptional talent. Andrew and Christina both have strong experience and training, and each add to the high caliber of the Burford team. We are confident that they will both add real value as we expand and deepen our business. The cost of these appointments was already in Burford's operating budget and cost base."

 

For further information, please contact:

FTI Consulting - PR for Burford CapitalEdward Berry +44 (0)20 7269 7297Laura Ewart +44 (0)20 7269 7243

About Burford

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with more than $300 million in capital and the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

For more information about Burford, visit www.burfordcapital.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSDFWMFDSEEE
Date   Source Headline
2nd Jul 202611:00 amRNSIssue of Equity in Connection with LTIP
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.